Literature DB >> 15888171

Permanent alopecia after busulfan chemotherapy.

A Tosti1, B M Piraccini, C Vincenzi, C Misciali.   

Abstract

Systemic chemotherapy is a well known cause of reversible hair loss. Busulfan chemotherapy, however, is responsible for a permanent alopecia that usually occurs in bone marrow transplant patients. We report two patients with permanent alopecia due to busulfan chemotherapy. Both patients had a diffuse alopecia characterized by greatly reduced hair density with short, thin hair. The pathology showed reduced follicular density in the absence of fibrosis, suggesting that alopecia may result either from hair follicle stem cell destruction or from acute damage to the keratinocytes of the lower portion of some follicles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888171     DOI: 10.1111/j.1365-2133.2005.06469.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

Review 1.  A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.

Authors:  Christopher John Dunnill; Wafaa Al-Tameemi; Andrew Collett; Iain Stuart Haslam; Nikolaos Theodoros Georgopoulos
Journal:  Oncologist       Date:  2017-09-26

2.  Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood.

Authors:  D Bresters; D C M Wanders; M Louwerens; L M Ball; M Fiocco; R van Doorn
Journal:  Bone Marrow Transplant       Date:  2017-03-20       Impact factor: 5.483

3.  Permanent chemotherapy-induced alopecia: awareness and attitudes among health care providers.

Authors:  Jenna R Stoehr; Cory Kosche; Jennifer N Choi
Journal:  Support Care Cancer       Date:  2019-11-19       Impact factor: 3.603

Review 4.  Identifying the supportive care needs of men and women affected by chemotherapy-induced alopecia? A systematic review.

Authors:  C Paterson; M Kozlovskaia; M Turner; K Strickland; C Roberts; R Ogilvie; G Pranavan; P Craft
Journal:  J Cancer Surviv       Date:  2020-07-18       Impact factor: 4.442

Review 5.  Hair disorders in cancer survivors.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Corina van den Hurk; Shari Goldfarb; Joaquin J Jimenez; Anthony M Rossi; Ralf Paus; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2018-04-14       Impact factor: 11.527

6.  Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study.

Authors:  F Bernard; P Auquier; I Herrmann; A Contet; M Poiree; F Demeocq; D Plantaz; C Galambrun; V Barlogis; J Berbis; F Garnier; N Sirvent; J Kanold; P Chastagner; H Chambost; G Michel
Journal:  Bone Marrow Transplant       Date:  2014-02-17       Impact factor: 5.483

7.  Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling.

Authors:  M Martín; J C de la Torre-Montero; S López-Tarruella; K Pinilla; A Casado; S Fernandez; Y Jerez; J Puente; I Palomero; R González Del Val; M Del Monte-Millan; T Massarrah; C Vila; B García-Paredes; J A García-Sáenz; A Lluch
Journal:  Breast Cancer Res Treat       Date:  2018-06-19       Impact factor: 4.872

8.  Clinical and histological study of permanent alopecia after bone marrow transplantation.

Authors:  Flávia Machado Alves Basilio; Fabiane Mulinari Brenner; Betina Werner; Graziela Junges Crescente Rastelli
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.